Effects of the Lifestyle Intervention Program GLICEMIA in People at Risk for Type 2 Diabetes: A Cluster-Randomized Controlled Trial

Publikationstyp:
Zeitschriftenaufsatz
Metadaten:
Autoren
  • Karin Schmiedel
  • Andreas Mayr
  • Cornelia Fiessler
  • Helmut Schlager
  • Kristina Friedland
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000353505600039&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.2337/dc14-2206
eISSN
1935-5548
Externe Identifier
  • Clarivate Analytics Document Solution ID: CG7SP
  • PubMed Identifier: 25784662
ISSN
0149-5992
Ausgabe der Veröffentlichung
5
Zeitschrift
DIABETES CARE
Paginierung
937 - 939
Datum der Veröffentlichung
2015
Status
Published
Titel
Effects of the Lifestyle Intervention Program GLICEMIA in People at Risk for Type 2 Diabetes: A Cluster-Randomized Controlled Trial
Sub types
  • Article
Ausgabe der Zeitschrift
38

Datenquelle: Web of Science (Lite)

Andere Metadatenquellen:
Abstract
<jats:sec> <jats:title>OBJECTIVE</jats:title> <jats:p>The aim of this study was to assess the efficacy of a 12-month prevention program conducted in 42 community pharmacies in reducing the risk for diabetes.</jats:p> </jats:sec> <jats:sec> <jats:title>RESEARCH DESIGN AND METHODS</jats:title> <jats:p>In a cluster-randomized controlled trial in 1,092 participants, mean change in the risk for diabetes (indicated by the Finnish Diabetes Risk Score [FINDRISC]) between intervention and control groups was calculated. In the intervention program GLICEMIA, three appointments with individual counseling and five educational group sessions were combined, whereas in the control group, only information about the participants’ health was obtained in three assessments.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>After adjusting for cluster structure and differences in baseline characteristics, improvement in FINDRISC in the intervention group was 0.74 points (95% CI 0.42–1.04) above the control group.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS</jats:title> <jats:p>The GLICEMIA program shows the feasibility of a pharmacy-based intervention and leads to a significant modest reduction in diabetes risk score but does not reduce the rate of diabetes progression over 1 year.</jats:p> </jats:sec>
Autoren
  • Karin Schmiedel
  • Andreas Mayr
  • Cornelia Fießler
  • Helmut Schlager
  • Kristina Friedland
DOI
10.2337/dc14-2206
eISSN
1935-5548
ISSN
0149-5992
Ausgabe der Veröffentlichung
5
Zeitschrift
Diabetes Care
Sprache
en
Online publication date
2015
Paginierung
937 - 939
Datum der Veröffentlichung
2015
Status
Published
Herausgeber
American Diabetes Association
Herausgeber URL
http://dx.doi.org/10.2337/dc14-2206
Datum der Datenerfassung
2022
Titel
Effects of the Lifestyle Intervention Program GLICEMIA in People at Risk for Type 2 Diabetes: A Cluster-Randomized Controlled Trial
Ausgabe der Zeitschrift
38

Datenquelle: Crossref

Abstract
<h4>Objective</h4>The aim of this study was to assess the efficacy of a 12-month prevention program conducted in 42 community pharmacies in reducing the risk for diabetes.<h4>Research design and methods</h4>In a cluster-randomized controlled trial in 1,092 participants, mean change in the risk for diabetes (indicated by the Finnish Diabetes Risk Score [FINDRISC]) between intervention and control groups was calculated. In the intervention program GLICEMIA, three appointments with individual counseling and five educational group sessions were combined, whereas in the control group, only information about the participants' health was obtained in three assessments.<h4>Results</h4>After adjusting for cluster structure and differences in baseline characteristics, improvement in FINDRISC in the intervention group was 0.74 points (95% CI 0.42-1.04) above the control group.<h4>Conclusions</h4>The GLICEMIA program shows the feasibility of a pharmacy-based intervention and leads to a significant modest reduction in diabetes risk score but does not reduce the rate of diabetes progression over 1 year.
Addresses
  • Scientific Institute for Prevention in Health Care (WIPIG), Munich, Germany.
Autoren
  • Karin Schmiedel
  • Andreas Mayr
  • Cornelia Fießler
  • Helmut Schlager
  • Kristina Friedland
DOI
10.2337/dc14-2206
eISSN
1935-5548
Externe Identifier
  • PubMed Identifier: 25784662
Funding acknowledgements
  • Bavarian State Corporate Health Insurers:
  • Bavarian State Ministry of Public Health and Care Services:
  • Funding Initiative for Prevention:
  • Dr. August and Dr. Anni Lesmüller-Foundation:
Open access
false
ISSN
0149-5992
Ausgabe der Veröffentlichung
5
Zeitschrift
Diabetes care
Schlüsselwörter
  • Humans
  • Diabetes Mellitus, Type 2
  • Disease Progression
  • Exercise
  • Cluster Analysis
  • Risk Factors
  • Prospective Studies
  • Feasibility Studies
  • Risk Reduction Behavior
  • Life Style
  • Counseling
  • Behavior Therapy
  • Quality of Life
  • Adult
  • Middle Aged
  • Community Pharmacy Services
  • Female
  • Male
Sprache
eng
Medium
Print-Electronic
Online publication date
2015
Paginierung
937 - 939
Datum der Veröffentlichung
2015
Status
Published
Datum der Datenerfassung
2015
Titel
Effects of the lifestyle intervention program GLICEMIA in people at risk for type 2 diabetes: a cluster-randomized controlled trial.
Sub types
  • Research Support, Non-U.S. Gov't
  • Multicenter Study
  • Randomized Controlled Trial
  • Journal Article
Ausgabe der Zeitschrift
38

Datenquelle: Europe PubMed Central

Abstract
OBJECTIVE: The aim of this study was to assess the efficacy of a 12-month prevention program conducted in 42 community pharmacies in reducing the risk for diabetes. RESEARCH DESIGN AND METHODS: In a cluster-randomized controlled trial in 1,092 participants, mean change in the risk for diabetes (indicated by the Finnish Diabetes Risk Score [FINDRISC]) between intervention and control groups was calculated. In the intervention program GLICEMIA, three appointments with individual counseling and five educational group sessions were combined, whereas in the control group, only information about the participants' health was obtained in three assessments. RESULTS: After adjusting for cluster structure and differences in baseline characteristics, improvement in FINDRISC in the intervention group was 0.74 points (95% CI 0.42-1.04) above the control group. CONCLUSIONS: The GLICEMIA program shows the feasibility of a pharmacy-based intervention and leads to a significant modest reduction in diabetes risk score but does not reduce the rate of diabetes progression over 1 year.
Date of acceptance
2015
Autoren
  • Karin Schmiedel
  • Andreas Mayr
  • Cornelia Fießler
  • Helmut Schlager
  • Kristina Friedland
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/25784662
DOI
10.2337/dc14-2206
eISSN
1935-5548
Ausgabe der Veröffentlichung
5
Zeitschrift
Diabetes Care
Schlüsselwörter
  • Adult
  • Behavior Therapy
  • Cluster Analysis
  • Community Pharmacy Services
  • Counseling
  • Diabetes Mellitus, Type 2
  • Disease Progression
  • Exercise
  • Feasibility Studies
  • Female
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Prospective Studies
  • Quality of Life
  • Risk Factors
  • Risk Reduction Behavior
Sprache
eng
Country
United States
Paginierung
937 - 939
PII
dc14-2206
Datum der Veröffentlichung
2015
Status
Published
Datum, an dem der Datensatz öffentlich gemacht wurde
2015
Titel
Effects of the lifestyle intervention program GLICEMIA in people at risk for type 2 diabetes: a cluster-randomized controlled trial.
Sub types
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Ausgabe der Zeitschrift
38

Datenquelle: PubMed

Beziehungen:
Eigentum von

Werkzeuge